Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.65 |
| ▸ | MAG | P20916 | 8/20 | 0.61 |
| ▸ | SELL | P14151 | 1/20 | 0.58 |
| ▸ | SELP | P16109 | 1/20 | 0.58 |
| ▸ | NANP | Q8TBE9 | 1/20 | 0.50 |
| ▸ | CD22 | P20273 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30483871 | 1.00 | SIGLEC7 (0.65) | SIGLEC7MAGSELLSELPNANP | |
| SCHEMBL17300130 | 0.94 | SELP (0.62) | SIGLEC7MAGSELLSELPNANP | |
| SCHEMBL29356627 | 0.94 | SELP (0.62) | SIGLEC7MAGSELLSELPNANP | |
| SCHEMBL29396615 | 0.94 | SELP (0.62) | SIGLEC7MAGSELLSELPNANP | |
| SCHEMBL29532796 | 0.91 | SIGLEC7 (0.72) | SIGLEC7MAGSELLSELP | |
| SCHEMBL30122574 | 0.91 | SIGLEC7 (0.72) | SIGLEC7MAGSELLSELP | |
| SCHEMBL29532570 | 0.91 | SIGLEC7 (0.72) | SIGLEC7MAGSELLSELP | |
| SCHEMBL31309218 | 0.91 | SIGLEC7 (0.57) | SIGLEC7MAGSELLSELPNANP | |
| SCHEMBL29437858 | 0.91 | SIGLEC7 (0.57) | SIGLEC7MAGSELLSELPNANP | |
| SCHEMBL29883057 | 0.91 | SIGLEC7 (0.57) | SIGLEC7MAGSELLSELPNANP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4702138-A1 | PRODUCTION OF A NEGATIVELY CHARGED OLIGOSACCHARIDE BY A CELL | Inbiose N.V. (BE) | 2026-03-04 | — | — | EP | claimed |
| EP-4651963-A1 | PURIFICATION OF AN OLIGOSACCHARIDE OR OLIGOSACCHARIDE MIXTURE | Inbiose N.V. (BE) | 2025-11-26 | — | — | EP | claimed |
| WO-2024223815-A1 | PRODUCTION OF A NEGATIVELY CHARGED OLIGOSACCHARIDE BY A CELL | INBIOSE N.V. (BE) | 2024-10-31 | — | — | WO | claimed |
| WO-2024153788-A1 | PURIFICATION OF AN OLIGOSACCHARIDE OR OLIGOSACCHARIDE MIXTURE | INBIOSE N.V. (BE) | 2024-07-25 | — | — | WO | claimed |
| EP-4731778-A2 | SIALYLTRANSFERASES FOR THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4702138-A1 | PRODUCTION OF A NEGATIVELY CHARGED OLIGOSACCHARIDE BY A CELL | Inbiose N.V. (BE) | 2026-03-04 | — | — | EP | disclosed |
| EP-4662224-A1 | PRODUCTION OF A SACCHARIDE BY A CELL WITH REDUCED SYNTHESIS OF LACTOBIONIC ACID | Inbiose N.V. (BE) | 2025-12-17 | — | — | EP | disclosed |
| EP-4662305-A1 | PRODUCTION OF A DISACCHARIDE AND/OR MILK OLIGOSACCHARIDE BY A CELL WITH REDUCED SYNTHESIS OF UDP-GLCNAC | Inbiose N.V. (BE) | 2025-12-17 | — | — | EP | disclosed |
| EP-4652174-A1 | PURIFICATION OF AN OLIGOSACCHARIDE OR OLIGOSACCHARIDE MIXTURE FROM A FERMENTATION BROTH | Inbiose N.V. (BE) | 2025-11-26 | — | — | EP | disclosed |
| EP-4651963-A1 | PURIFICATION OF AN OLIGOSACCHARIDE OR OLIGOSACCHARIDE MIXTURE | Inbiose N.V. (BE) | 2025-11-26 | — | — | EP | disclosed |
| EP-4652175-A1 | PURIFICATION OF A SACCHARIDE FROM A FERMENTATION BROTH | Inbiose N.V. (BE) | 2025-11-26 | — | — | EP | disclosed |
| EP-4608849-A1 | SACCHARIDE IMPORTERS FOR LACTO-N-TRIOSE | Inbiose N.V. (BE) | 2025-09-03 | — | — | EP | disclosed |
| EP-4192969-A1 | PRODUCTION OF AN OLIGOSACCHARIDE MIXTURE BY A CELL | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | disclosed |
| EP-4192944-A1 | PRODUCTION OF OLIGOSACCHARIDE MIXTURES BY A CELL | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | disclosed |
| EP-4192945-A1 | CELLULAR PRODUCTION OF SIALYLATED DI- AND/OR OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | disclosed |
| EP-4192965-A1 | METHOD TO PRODUCE A PURIFIED MIXTURE OF DIFFERENT OLIGOSACCHARIDES PRODUCED BY CELL CULTIVATION OR MICROBIAL FERMENTATION | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | disclosed |
| EP-4192974-A1 | PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | disclosed |
| EP-4192946-A1 | CELLULAR PRODUCTION OF DI- AND/OR OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | disclosed |
| WO-2022219187-A1 | CELLULAR PRODUCTION OF BIOPRODUCTS | INBIOSE N.V. (BE) | 2022-10-20 | — | — | WO | disclosed |
| US-20220251619-A1 | Method of Sialylating a Protein | THE UNIVERSITY OF MANCHESTER (GB) | 2022-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220251619-A1 | Method of Sialylating a Protein | ST6GAL1, NEU2, NEU1 | SIGLEC7 22/4885MAG 681/4885SELL 299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.